ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,988Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 143

$673K Total Retail Price of All Prescriptions

Rank: 13 out of 143

224 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 224 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 224 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 10,487 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 524 514 1 6
LEVOTHYROXINE SODIUM 390 368 2 3
LISINOPRIL 383 333 3 1
CARVEDILOL 315 267 4 22
POLYETHYLENE GLYCOL 3350 293 264 5 45
DONEPEZIL HCL 278 270 6 36
AMLODIPINE BESYLATE 216 188 7 4
ESCITALOPRAM OXALATE 215 214 8 46
METOPROLOL TARTRATE 203 192 9 12
TRAMADOL HCL 200 172 10 16
LANTUS 193 177 11 65
ATORVASTATIN CALCIUM 189 165 12 7
OMEPRAZOLE 181 174 13 5
WARFARIN SODIUM 170 95 14 15
QUETIAPINE FUMARATE 159 141 15 53
IPRATROPIUM-ALBUTEROL 158 118 16 103
GABAPENTIN 158 116 16 18
SIMVASTATIN 155 128 18 2
MIRTAZAPINE 146 143 19 30
HYDROCHLOROTHIAZIDE 144 118 20 10
CYMBALTA 143 94 21 47
METFORMIN HCL 141 104 22 8
ADVAIR DISKUS 136 121 23 42
ABILIFY 130 118 24 125
DIGOXIN 128 124 25 71
NAMENDA 124 117 26 49
TAMSULOSIN HCL 123 116 27 28
SERTRALINE HCL 121 106 28 23
PLAVIX 121 106 28 51
RISPERIDONE 118 106 30 61
CLOPIDOGREL 118 101 30 33
ATENOLOL 109 109 32 11
JANUVIA 108 108 33 54
LIDODERM 107 93 34 129
KLOR-CON M20 103 79 35 69
ISOSORBIDE MONONITRATE ER 101 84 36 44
JANTOVEN 94 68 37 179
METOPROLOL SUCCINATE 93 87 38 14
LEVETIRACETAM 90 56 39 74
BUPROPION XL 89 80 40 88
CLONIDINE HCL 85 68 41 120
CARBIDOPA-LEVODOPA 84 84 42 93
OXYCONTIN 83 38 S2 43 111
ROPINIROLE HCL 81 67 44 90
ALBUTEROL SULFATE 81 74 44 102
HYDRALAZINE HCL 80 63 46 64
KLOR-CON M10 79 78 47 99
PRAVASTATIN SODIUM 77 64 48 9
AMOX TR-POTASSIUM CLAVULANATE 76 73 49 112
LYRICA 75 55 50 96
CIPROFLOXACIN HCL 74 72 51 58
LEVOFLOXACIN 68 64 52 68
DIVALPROEX SODIUM 67 63 53 80
PAROXETINE HCL 65 65 54 79
TRAZODONE HCL 64 58 55 59
SPIRIVA 63 53 56 38
CITALOPRAM HBR 59 27 57 25
BUPROPION HCL SR 59 55 57 205
LEXAPRO 59 55 57 141
DIOVAN 58 55 60 26
SINGULAIR 56 44 61 148
BRIMONIDINE TARTRATE 56 54 61 156
DILTIAZEM 24HR CD 55 48 63 140
DOXAZOSIN MESYLATE 54 54 64 91
LATANOPROST 50 49 65 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.